Subject
Psychiatry and Mental health,Geriatrics and Gerontology
Reference8 articles.
1. Pharmacogenetic implications for antidepressant pharmacotherapy in late-life depression: a systematic review of the literature for response, pharmacokinetics and adverse drug reactions;Marshe;Am J Geriatr Psychiatry,2020
2. Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: a large, patient- and rater-blinded, randomized, controlled study;Greden;J Psychiatr Res,2019
3. Effects of pharmacogenetic screening for CYP2D6 among elderly starting therapy with nortriptyline or venlafaxine: a pragmatic randomized controlled trial (CYSCE Trial);van der Schans;J Clin Psychopharmacol,2019
4. Genetic variation in CYP3A43 explains racial difference in olanzapine clearance;Bigos;Mol Psychiatry,2011
5. Sex, race, and smoking impact olanzapine exposure;Bigos;J Clin Pharmacol,2008